Literature DB >> 18375304

Inflammation and recanalization of four different spherical embolization agents in the porcine kidney model.

Sibylle Stampfl1, Nadine Bellemann, Ulrike Stampfl, Boris Radeleff, Ruben Lopez-Benitez, Christof-Matthias Sommer, Heidi Thierjung, Irina Berger, Goetz M Richter.   

Abstract

PURPOSE: To evaluate the pattern of recanalization and specific inflammatory reaction after superselective embolization with four commercially available spherical embolic agents of different sizes in the mini pig kidney model.
MATERIALS AND METHODS: In 40 mini pigs, the lower poles of both kidneys were superselectively embolized with Embozene, Embosphere, Bead Block, and Contour SE particles in sizes of 40-120 mircom (Embozene, Embosphere) and 100-300 microm, 500-700 microm, and 700-900 microm (Embozene, Embosphere, Bead Block, Contour SE). After a follow-up time of 4 or 12 weeks, recanalization was determined with angiography. Pathologic and histologic evaluation of the kidneys was performed, and the Banff 97 classification was used to evaluate the extent of vessel wall inflammation. Macroscopically visible ischemic changes were evaluated by using a specific ischemia score.
RESULTS: After embolization with Embozene microspheres, larger Embosphere particles, and Bead Block and Contour SE particles, the absence of inflammation or a low inflammation score was observed. Significantly elevated inflammation scores were evident with small Embosphere particles after 4 weeks (mean score, 1.21 +/- 1.0). Distinct recanalization occurred with Contour SE particles (100% recanalization with 100-300-microm particles at 12 weeks, 500-700-microm particles at 4 and 12 weeks, and 700-900-microm particles at 4 weeks). Ischemia scores were highest in the target area in all specimens. Mildly elevated ischemia scores in nontarget tissue areas were indicative of minor nontarget embolization.
CONCLUSIONS: Except for small Embosphere particles at 4 weeks, the absence of inflammatory reaction to the embolization procedure or only low inflammatory changes were observed with all embolic agents, particle sizes, and follow-up intervals. Recanalization was evident with all embolic agents; however, it was pronounced with Contour SE particles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375304     DOI: 10.1016/j.jvir.2008.01.011

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

1.  In vivo evaluation of callispheres microspheres in the porcine renal artery embolization model.

Authors:  Baosheng Ren; Wansheng Wang; Jian Shen; Caifang Ni; Xiaoli Zhu
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 2.  Polymeric materials for embolic and chemoembolic applications.

Authors:  Azadeh Poursaid; Mark Martin Jensen; Eugene Huo; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2016-02-26       Impact factor: 9.776

3.  Transarterial Embolization Modulates the Immune Response within Target and Nontarget Hepatocellular Carcinomas in a Rat Model.

Authors:  David J Tischfield; Alexey Gurevich; Omar Johnson; Isabela Gatmaytan; Gregory J Nadolski; Michael C Soulen; David E Kaplan; Emma Furth; Stephen J Hunt; Terence P F Gade
Journal:  Radiology       Date:  2022-01-11       Impact factor: 29.146

4.  Evaluation of arterial impairment after experimental gelatin sponge embolization in a rabbit renal model.

Authors:  Jung Suk Oh; Hae Giu Lee; Ho Jong Chun; Byung Gil Choi; Yeong Jin Choi
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

5.  Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings.

Authors:  José I Bilbao; Alba de Martino; Esther de Luis; Lourdes Díaz-Dorronsoro; Alberto Alonso-Burgos; Antonio Martínez de la Cuesta; Bruno Sangro; José A García de Jalón
Journal:  Cardiovasc Intervent Radiol       Date:  2009-05-16       Impact factor: 2.740

Review 6.  Endoluminal occlusion devices: technology update.

Authors:  Tobias Zander; Samantha Medina; Guillermo Montes; Lourdes Nuñez-Atahualpa; Michel Valdes; Manuel Maynar
Journal:  Med Devices (Auckl)       Date:  2014-12-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.